FDA Inspection 1118219 — Bio-Signal Group Corp.

Bio-Signal Group Corp. — FEI 3006315274

The FDA completed an inspection of Bio-Signal Group Corp. on February 19, 2020 in Acton, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 19, 2020
Fiscal Year
2020
Product Type
Devices
Project Area
Compliance: Devices
Location
Acton, MA (United States)

Citations

IDCFRDescription
1472021 CFR 820.50(a)(3)Acceptable supplier records, inadequate records
312821 CFR 820.90(a)Nonconforming product control
316821 CFR 820.198(a)Complaints